N-24 (metabolin) NDC 58264-0222

NDC codes

FDA NDC Directory

Product NDC (as listed)58264-0222Labeler and product segments. Claims need a package NDC.

Product NDC at billing width58264-0222Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
58264-0222-1	58264022201	29.57 mL in 1 BOTTLE, GLASS (58264-0222-1)Marketed from Jan 1, 1990

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): N-24
Generic name (nonproprietary): metabolin
Active ingredients: Arginine — 12 [hp_X]/mLCysteine — 12 [hp_X]/mLGlutamine — 12 [hp_X]/mLSaccharomyces cerevisiae RNA — 30 [hp_X]/mLHerring sperm DNA — 30 [hp_X]/mLBos taurus adrenal gland — 200 [hp_X]/mLSus scrofa pineal gland — 200 [hp_X]/mLBos taurus parotid gland — 200 [hp_X]/mLBos taurus pituitary gland, Posterior — 200 [hp_X]/mLBos taurus prostate gland — 200 [hp_X]/mLThyroid, Unspecified — 200 [hp_X]/mLCalcium fluoride — 30 [hp_X]/mLTribasic calcium phosphate — 30 [hp_X]/mLCalcium sulfate anhydrous — 30 [hp_X]/mLFerrosoferric phosphate — 30 [hp_X]/mLPotassium chloride — 30 [hp_X]/mLDibasic potassium phosphate — 30 [hp_X]/mLPotassium sulfate — 30 [hp_X]/mLMagnesium phosphate, Dibasic trihydrate — 30 [hp_X]/mLSodium chloride — 30 [hp_X]/mLSodium phosphate, Dibasic, Heptahydrate — 30 [hp_X]/mLSodium sulfate — 30 [hp_X]/mLSilicon dioxide — 30 [hp_X]/mL
Dosage form: Solution
Route: Sublingual
Labeler: DNA Labs, Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jan 1, 1990
Listing expires: Dec 31, 2026
Other FDA classes: Amino Acids (Chemical structure)Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Potassium Compounds (Chemical structure)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 58264-0222_2b53a072-a78c-f719-e063-6394a90a647aSPL ID 2b53a072-a78c-f719-e063-6394a90a647aSPL set ID 559fca2b-1093-4bdf-be70-c453f87002c3UNII 94ZLA3W45F, K848JZ4886, 0RH81L854J, J17GBZ5VGX, 51FI676N6F, M2776SWB29, 050QZ2EDK7, 6NWC5E4H38, 7JM57I419K, 1P66FXU2MW, 0B4FDL9I6P, O3B55K4YKI, 91D9GV0Z28, E934B3V59H, 91GQH8I5F7, 660YQ98I10, CI71S98N1Z, 1K573LC5TV, HF539G9L3Q, 451W47IQ8X, 70WT22SF4B, 0YPR65R21J, ETJ7Z6XBU4
Pharmacologic class: Amino Acid; Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Sublingual products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N458264022201 followed by a unit qualifier and the quantity

Package 58264-0222-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 9, 2025.

Indications (excerpt from the label)

INDICATIONS Assists the metabolic balance in the body; enhances the feeling of wellbeing.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)